During the past decade, Netherlands Institute for Innovative Ocular Surgery conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Netherlands Institute for Innovative Ocular Surgery" #1 collaborator was "Amnitrans Eyebank Rotterdam" with 3 trials as a collaborator and "Melles CorneaClinic Rotterdam" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Netherlands Institute for Innovative Ocular Surgery" are "Corneal Dystrophies, Hereditary" (2 trials) and "Advanced Keratoconus" (1 trials). Many other conditions were trialed in "Netherlands Institute for Innovative Ocular Surgery" in a lesser frequency.

Most popular intervention types in "Netherlands Institute for Innovative Ocular Surgery" are "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bowman layer graft implantation" (1 trials), "Descemet Membrane Endothelial Keratoplasty (DMEK)" (1 trials) and "Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Netherlands Institute for Innovative Ocular Surgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Netherlands Institute for Innovative Ocular Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Netherlands Institute for Innovative Ocular Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Netherlands Institute for Innovative Ocular Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".